2026 has brought a plethora of converging technological change and regulatory updates to the life sciences industry at an unprecedented pace. Despite shifts in key compliance frameworks and ongoing digitalisation across the entire pharmaceutical value chain, many organisations still rely on paper-based legacy systems and siloed compliance methods, leaving themselves highly susceptible to manual errors and noncompliance. Jessica Madsen, Senior Product Marketing Manager at MasterControl, shares her insights on the importance of departing from traditional approaches and the consequences of remaining static.
Amid unprecedented regulatory change, what macro trends are driving compliance urgency for manufacturers?
Jessica Madsen: The pace of regulatory change is particularly challenging because it is converging from multiple directions simultaneously. The FDA’s QMSR update aligned 21 CFR Part 820 with ISO 13485, the EU’s revised Annex 1 set new benchmarks for aseptic processing that will influence decisions well beyond European borders, and regulators worldwide are tightening expectations around data integrity and electronic records. A compliance gap in one jurisdiction is increasingly a gap everywhere.
Data integrity has become a defining compliance risk. Paper-based systems and hybrid environments where data is manually transcribed between disconnected systems simply can’t satisfy that standard consistently. A missing batch record or a manually assembled audit package is a liability that can cascade through an entire inspection.
The AI compliance imperative is arriving faster than most organisations are ready for. New FDA and EMA guidance on explainable AI and data integrity requirements adds a compliance layer that most current systems were never designed to handle. The manufacturers feeling the most urgency are running disconnected quality, manufacturing, and asset management systems where every regulatory change requires manual reconciliation across multiple platforms.
Why do disconnected legacy systems keep manufacturers trapped in siloed compliance cycles?
JM: Life sciences manufacturers understand legacy infrastructure risks, yet 70% of manufacturing capacity remains paper-based. The most common trap is approaching digital change defensively, adding point tools like SharePoint or standalone QMS (quality management system) solutions to fix isolated pain points without addressing underlying architecture. This creates a fractured patchwork of disconnected systems. When deviations occur, quality teams must manually retrieve batch data, operator training records, and equipment status from multiple sources, making investigations slow, error-prone, and reactive.
Historically, modernisation has been blocked by validation anxiety and cost; traditional MES deployments routinely require 12 to 18 months and upwards of $1M, putting them out of reach for most lines.
Successful companies, however, treat digital transformation as a lever for compliance, rather than a risk. They replace fractured systems with modern platforms that unify manufacturing execution, quality, and asset management. This integration enables real-time traceability, transforming compliance from an administrative burden into a natural byproduct of daily operations.
What are the economic consequences for organisations that fail to maintain quality control and compliance?
JM: FDA-initiated product recalls have increased 115% since 2018, hitting the pharmaceutical and medical device industries hardest. McKinsey estimates a single recall or warranty process can cost a manufacturer up to $600 million, and that figure excludes litigation, supply chain removal costs, and reputational damage. Across the medical device industry alone, total recall costs reach as much as $5 billion annually.
The most common violations cited in FDA warning letters are precisely the failure modes that disconnected, paper-based systems are structurally incapable of preventing. Organisations that cannot demonstrate consistent, documented quality control lose market access, contract opportunities, and the trust of partners and regulators simultaneously.
The inverse is equally true. Organisations that build quality into operational infrastructure are positioned to adapt faster to regulatory changes, absorb new business without disruption, and compete in markets where digital maturity has become a baseline expectation.
How can organisations eliminate paper records to mitigate data integrity risks?
JM: The FDA cited poor manufacturing data integrity in nearly 80% of warning letters issued over the last five years, and almost 40% of all deviations trace back to human failure.
MasterControl’s Mx (Manufacturing Excellence platform) solves this by delivering 100% paperless data input directly at the point of execution – digitising batch records, eDHRs, travellers, and logbooks so that data is captured accurately and never reconciled from a paper form. Mx embeds built-in limits, thresholds, and current SOPs directly into the operator’s workflow at the moment of entry, thereby flagging issues and guiding execution in real time.
Leveraging this platform, customers have reported a 90 to 100% reduction in data entry errors, a 25 to 30% reduction in total deviations, and batch review cycles compressed from two to three days to 15 minutes.
How can organisations embed automated compliance across their daily operations?
JM: An issue with siloed quality management is that compliance becomes a periodic sprint rather than a consistent state. However, our Qx (Quality Excellence) platform looks to remedy this.
Qx connects document control, training, and quality event management so that a change in one automatically triggers the appropriate response in the others. When a document is revised, the system immediately pushes updated training tasks to every affected employee. When a deviation or nonconformance occurs, a CAPA (corrective action/preventive action) can be initiated directly from the quality event form without manual re-entry.
Instead of managing spreadsheets or disconnected point solutions, every process is automated and interconnected. Quality therefore transforms from being something managed in isolation to something the entire organisation produces continuously.
How can organisations limit equipment downtime and avoid calibration gaps?
JM: Most life sciences organisations have separate calibration, maintenance, and CMMS (computerized maintenance management system) tools in silos, causing wasted time in duplicated effort and data normalization. Our Asset Management platform (Ax) eliminates this complexity by unifying an entire organization’s maintenance and metrology-based calibration in one system, providing audit-ready asset histories in a single, compliance-first platform.
What distinguishes Ax from generic CMMS solutions is its native metrology engine. Rather than tracking calibration as a scheduled task, Ax links precision measurements directly to asset records and compliance reports, enforcing ISO 17025, FDA, and GMP standards with auto-generated calibration certificates, real-time tolerance tracking, and integrated uncertainty calculations.
On the maintenance side, Ax moves organisations from reactive firefighting to proactive asset management, automatically generating work orders based on time, usage, or condition data, with full audit trails at every step. The result is equipment that stays in a continuous state of control, and compliance documentation that’s always audit-ready.
How does unifying these three components onto MasterControl’s ADAPT Platform drive long-term value for the life sciences landscape?
JM: ADAPT is the shared data and intelligence foundation across Qx, Mx, and Ax. Rather than connecting three separate systems through integrations and data exports, all three operate within a single data model and governed environment. When a deviation is flagged on the production floor, quality records, equipment history, and training status are all immediately accessible in context without manual aggregation, data leaving compliance boundaries, or reconciliation lag. For life sciences manufacturers, the practical result is faster investigations, easier audits, and dramatically less validation.
Download the report below to discover how MasterControl’s solutions can help secure your digital compliance
